BL
Insider
Biotechnology Value Trading Fund OS LP
DirectorBiotechnology Value Trading Fund OS LP (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in Kymera Therapeutics, Inc. (KYMR). Across 1 priced purchase filing, the average 21-session return was -2.1% from execution and -2.1% from disclosure (delay-adjusted; derived). The largest single filing was $14.0M of KYMR (317,167 sh across 3 lots, as filed), executed Jun 30 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-2.1%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-2.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$14.0M
shares × price, as filed
Last traded
Jun 30 2025
Filed Jul 1 2025
Median ADV $102.3M across their filed names
Open performance→Volume by month
Buys $14.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
KYMRRecent filings
KYMRPURCHASE
Kymera Therapeutics, Inc.
View filing →
$14.0M317,167 sh across 3 lots
Exec Jun 30 2025
Filed Jul 1 2025 · 5:30 PM ET